United States Biotechnology & Medical Research

Immuneering Corp (IMRX)

Track

Track

Immuneering Corp experienced two insider transactions over the past ninety days, both involving executive purchases totaling 35,993.33 USD. These acquisitions occurred following the most recent earnings report, which reflected a slight miss in EPS. The stock price has risen 9.7 percent during this period, remaining well below its annual peak.
Ticker: IMRX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Immuneering Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.4
Zeskind Benjamin J. PRESIDENT AND CEO Executive Director
Transaction date
Purchase
Price
233.88
Quantity 39,378 -15.5%
Value US$2,498,422
3.9
Hall Brett Matthew CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Purchase
Price
274.22
Quantity 19,997 -4.3%
Value US$4,013,257
3.3
Brakewood Harold Eugene Chief Business Officer Officer
Transaction date
Purchase
Price
179.63
Quantity 23,955 -38.3%
Value US$3,991,038
4.0
Schall Thomas J. Non-Executive Director
Transaction date
Purchase
Price
4.67
Quantity 21,645 +40.9%
Value US$101,041
3.9
Hall Brett Matthew CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Purchase
Price
4.57
Quantity 2,298 +0.6%
Value US$10,502
2.6
Neufeld Leah R CHIEF PEOPLE OFFICER Officer
Transaction date
Purchase
Price
4.15
Quantity 2,626 +11.2%
Value US$10,906
2.6
Feinberg Peter Non-Executive Director
Transaction date
Purchase
Price
4.35
Quantity 20,000 +17.3%
Value US$86,904
2.6
Feinberg Peter Non-Executive Director
Transaction date
Purchase
Price
6.67
Quantity 7,500 +5.0%
Value US$50,025
1.4
Morales Mallory Chief Accounting Officer Officer
Transaction date
Purchase
Price
6.39
Quantity 300 +1.1%
Value US$1,917
2.6
Neufeld Leah R CHIEF PEOPLE OFFICER Officer
Transaction date
Purchase
Price
6.38
Quantity 800 +3.5%
Value US$5,103
2.8
Bookman Michael CHIEF LEGAL OFFICER, SECRETARY Officer
Transaction date
Purchase
Price
6.83
Quantity 1,020 +26.5%
Value US$6,966
2.6
Feinberg Peter Non-Executive Director
Transaction date
Purchase
Price
7.03
Quantity 7,500 +5.3%
Value US$52,730
2.6
Feinberg Peter Non-Executive Director
Transaction date
Purchase
Price
7.18
Quantity 5,000 +3.7%
Value US$35,900
3.0
BERMAN ANN E Director Non-Executive Director
Transaction date
Proposed sale
Price
9.72
Quantity 14,000
Value US$136,080
2.6
Neufeld Leah R CHIEF PEOPLE OFFICER Officer
Transaction date
Purchase
Price
3.57
Quantity 700 +7.0%
Value US$2,499
3.7
HAUSMAN DIANA Non-Executive Director
Transaction date
Purchase
Price
3.62
Quantity 3,000 +inf%
Value US$10,874
3.7
HAUSMAN DIANA Non-Executive Director
Transaction date
Purchase
Price
3.60
Quantity 2,500 +inf%
Value US$8,989
3.4
Zeskind Benjamin J. PRESIDENT AND CEO Executive Director Large shareholder
Transaction date
Purchase
Price
3.53
Quantity 7,015 +0.3%
Value US$24,792
3.4
Zeskind Benjamin J. PRESIDENT AND CEO Executive Director Large shareholder
Transaction date
Purchase
Price
3.38
Quantity 2,985 +0.1%
Value US$10,087
4.0
Schall Thomas J. Non-Executive Director
Transaction date
Purchase
Price
3.66
Quantity 9,500 +21.9%
Value US$34,788
3.9
Hall Brett Matthew CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Purchase
Price
2.43
Quantity 6,007 +1.7%
Value US$14,596
3.9
Hall Brett Matthew CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Purchase
Price
2.70
Quantity 7,415 +2.1%
Value US$20,020
3.3
Brakewood Harold Eugene Chief Business Officer Officer
Transaction date
Purchase
Price
2.53
Quantity 1,900 +48.7%
Value US$4,804
2.6
Feinberg Peter Non-Executive Director
Transaction date
Purchase
Price
2.53
Quantity 25,000 +22.4%
Value US$63,188
3.4
Zeskind Benjamin J. PRESIDENT AND CEO Executive Director Large shareholder
Transaction date
Purchase
Price
2.39
Quantity 21,000 +0.9%
Value US$50,144
4.0
Schall Thomas J. Non-Executive Director
Transaction date
Purchase
Price
2.21
Quantity 40,485 +1396.0%
Value US$89,278
4.0
Schall Thomas J. Non-Executive Director
Transaction date
Purchase
Price
2.55
Quantity 2,900 +inf%
Value US$7,385
2.6
Feinberg Peter Non-Executive Director
Transaction date
Purchase
Price
2.55
Quantity 25,000 +28.8%
Value US$63,712
3.3
Brakewood Harold Eugene Chief Business Officer Officer
Transaction date
Purchase
Price
2.57
Quantity 3,900 +inf%
Value US$10,015
1.4
Morales Mallory Chief Accounting Officer Officer
Transaction date
Purchase
Price
2.55
Quantity 393 +5.0%
Value US$1,000
1.4
Morales Mallory Chief Accounting Officer Officer
Transaction date
Purchase
Price
2.72
Quantity 1,107 +16.3%
Value US$3,009
3.9
Hall Brett Matthew CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Purchase
Price
2.86
Quantity 7,000 +2.1%
Value US$20,020
2.6
Neufeld Leah R CHIEF PEOPLE OFFICER Officer
Transaction date
Purchase
Price
2.88
Quantity 3,818 +61.5%
Value US$10,993
2.6
Feinberg Peter Non-Executive Director
Transaction date
Purchase
Price
2.56
Quantity 25,000 +40.5%
Value US$64,000
3.4
Zeskind Benjamin J. PRESIDENT AND CEO Executive Director Large shareholder
Transaction date
Purchase
Price
2.77
Quantity 20,000 +0.9%
Value US$55,326
2.6
Feinberg Peter Non-Executive Director
Transaction date
Purchase
Price
3.05
Quantity 4,976 +8.8%
Value US$15,201
2.6
Feinberg Peter Non-Executive Director
Transaction date
Purchase
Price
2.31
Quantity 45,024 +382.7%
Value US$103,857
3.0
BERMAN ANN E Non-Executive Director
Transaction date
Purchase
Price
2.13
Quantity 57,965 +610.2%
Value US$123,436
3.9
Hall Brett Matthew CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Purchase
Price
3.92
Quantity 2,551 +0.8%
Value US$10,000
2.8
Bookman Michael GENERAL COUNSEL AND SECRETARY Officer
Transaction date
Purchase
Price
4.88
Quantity 1,000 +71.3%
Value US$4,880
2.2
KEATING LAURIE Non-Executive Director
Transaction date
Purchase
Price
5.00
Quantity 7,000 +100.0%
Value US$35,000
3.2
Amin Biren CFO, TREASURER Officer
Transaction date
Purchase
Price
4.42
Quantity 1,000 +14.5%
Value US$4,420
3.4
Zeskind Benjamin J. PRESIDENT AND CEO Executive Director Large shareholder
Transaction date
Purchase
Price
8.02
Quantity 3,000 +0.1%
Value US$24,060
3.9
Hall Brett Matthew CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Purchase
Price
7.91
Quantity 1,050 +0.3%
Value US$8,306
2.1
Barrett Scott CHIEF MEDICAL OFFICER Officer
Transaction date
Purchase
Price
7.49
Quantity 900 +13.5%
Value US$6,736
2.6
Feinberg Peter Non-Executive Director
Transaction date
Purchase
Price
6.75
Quantity 6,667 +130.8%
Value US$45,002
3.0
BERMAN ANN E Non-Executive Director
Transaction date
Purchase
Price
6.40
Quantity 6,000 +171.4%
Value US$38,400
3.4
Zeskind Benjamin J. PRESIDENT AND CEO Executive Director Large shareholder
Transaction date
Purchase
Price
22.87
Quantity 2,083 +0.1%
Value US$47,632
2.6
Feinberg Peter Non-Executive Director
Transaction date
Purchase
Price
15.00
Quantity 33,333 +40.6%
Value US$499,995
2.6
Feinberg Peter Non-Executive Director
Transaction date
Purchase
Price
15.00
Quantity 129,167 +37.2%
Value US$1,937,505
2.6
Feinberg Peter Non-Executive Director
Transaction date
Purchase
Price
15.00
Quantity 129,167 +50.2%
Value US$1,937,505
3.2
Amin Biren CFO, Treasurer Officer
Transaction date
Purchase
Price
15.00
Quantity 4,175 +153.3%
Value US$62,625
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-24 2026-06-23 B Purchase
3.4
Zeskind Benjamin J.

PRESIDENT AND CEO

Executive Director
39,378 -15.5%
233.88
US$2,498,422 		39,378 -15.5% 233.88 US$2,498,422
2026-06-16 2026-06-15 B Purchase
3.9
Hall Brett Matthew

CHIEF SCIENTIFIC OFFICER

Officer
19,997 -4.3%
274.22
US$4,013,257 		19,997 -4.3% 274.22 US$4,013,257
2026-01-21 2026-01-16 B Purchase
3.3
Brakewood Harold Eugene

Chief Business Officer

Officer
23,955 -38.3%
179.63
US$3,991,038 		23,955 -38.3% 179.63 US$3,991,038
2026-01-20 2026-01-15 B Purchase
4.0
Schall Thomas J.
Non-Executive Director
21,645 +40.9%
4.67
US$101,041 		21,645 +40.9% 4.67 US$101,041
2026-01-16 2026-01-15 B Purchase
3.9
Hall Brett Matthew

CHIEF SCIENTIFIC OFFICER

Officer
2,298 +0.6%
4.57
US$10,502 		2,298 +0.6% 4.57 US$10,502
2026-01-15 2026-01-13 B Purchase
2.6
Neufeld Leah R

CHIEF PEOPLE OFFICER

Officer
2,626 +11.2%
4.15
US$10,906 		2,626 +11.2% 4.15 US$10,906
2026-01-14 2026-01-12 B Purchase
2.6
Feinberg Peter
Non-Executive Director
20,000 +17.3%
4.35
US$86,904 		20,000 +17.3% 4.35 US$86,904
2025-10-07 2025-10-03 B Purchase
2.6
Feinberg Peter
Non-Executive Director
7,500 +5.0%
6.67
US$50,025 		7,500 +5.0% 6.67 US$50,025
2025-10-02 2025-10-01 B Purchase
1.4
Morales Mallory

Chief Accounting Officer

Officer
300 +1.1%
6.39
US$1,917 		300 +1.1% 6.39 US$1,917
2025-10-02 2025-10-01 B Purchase
2.6
Neufeld Leah R

CHIEF PEOPLE OFFICER

Officer
800 +3.5%
6.38
US$5,103 		800 +3.5% 6.38 US$5,103
2025-10-02 2025-10-01 B Purchase
2.8
Bookman Michael

CHIEF LEGAL OFFICER, SECRETARY

Officer
1,020 +26.5%
6.83
US$6,966 		1,020 +26.5% 6.83 US$6,966
2025-10-01 2025-09-30 B Purchase
2.6
Feinberg Peter
Non-Executive Director
7,500 +5.3%
7.03
US$52,730 		7,500 +5.3% 7.03 US$52,730
2025-09-30 2025-09-29 B Purchase
2.6
Feinberg Peter
Non-Executive Director
5,000 +3.7%
7.18
US$35,900 		5,000 +3.7% 7.18 US$35,900
2025-09-23 2025-09-23 PrS Proposed sale
3.0
BERMAN ANN E

Director

Non-Executive Director
14,000
9.72
US$136,080 		14,000 9.72 US$136,080
2025-07-07 2025-07-02 B Purchase
2.6
Neufeld Leah R

CHIEF PEOPLE OFFICER

Officer
700 +7.0%
3.57
US$2,499 		700 +7.0% 3.57 US$2,499
2025-07-07 2025-07-02 B Purchase
3.7
HAUSMAN DIANA
Non-Executive Director
3,000 +inf%
3.62
US$10,874 		3,000 +inf% 3.62 US$10,874
2025-07-07 2025-07-02 B Purchase
3.7
HAUSMAN DIANA
Non-Executive Director
2,500 +inf%
3.60
US$8,989 		2,500 +inf% 3.60 US$8,989
2025-07-03 2025-07-02 B Purchase
3.4
Zeskind Benjamin J.

PRESIDENT AND CEO

Executive Director Large shareholder
7,015 +0.3%
3.53
US$24,792 		7,015 +0.3% 3.53 US$24,792
2025-07-03 2025-07-01 B Purchase
3.4
Zeskind Benjamin J.

PRESIDENT AND CEO

Executive Director Large shareholder
2,985 +0.1%
3.38
US$10,087 		2,985 +0.1% 3.38 US$10,087
2025-06-30 2025-06-27 B Purchase
4.0
Schall Thomas J.
Non-Executive Director
9,500 +21.9%
3.66
US$34,788 		9,500 +21.9% 3.66 US$34,788
2025-06-24 2025-06-23 B Purchase
3.9
Hall Brett Matthew

CHIEF SCIENTIFIC OFFICER

Officer
6,007 +1.7%
2.43
US$14,596 		6,007 +1.7% 2.43 US$14,596
2025-06-24 2025-06-20 B Purchase
3.9
Hall Brett Matthew

CHIEF SCIENTIFIC OFFICER

Officer
7,415 +2.1%
2.70
US$20,020 		7,415 +2.1% 2.70 US$20,020
2025-06-24 2025-06-20 B Purchase
3.3
Brakewood Harold Eugene

Chief Business Officer

Officer
1,900 +48.7%
2.53
US$4,804 		1,900 +48.7% 2.53 US$4,804
2025-06-23 2025-06-18 B Purchase
2.6
Feinberg Peter
Non-Executive Director
25,000 +22.4%
2.53
US$63,188 		25,000 +22.4% 2.53 US$63,188
2025-06-20 2025-06-18 B Purchase
3.4
Zeskind Benjamin J.

PRESIDENT AND CEO

Executive Director Large shareholder
21,000 +0.9%
2.39
US$50,144 		21,000 +0.9% 2.39 US$50,144
2025-06-18 2025-06-17 B Purchase
4.0
Schall Thomas J.
Non-Executive Director
40,485 +1396.0%
2.21
US$89,278 		40,485 +1396.0% 2.21 US$89,278
2024-04-03 2024-04-01 S Sale
3.7
Cormorant Asset Management, LP
Large shareholder
398,600 -12.1%
2.90
US$1,155,940 		398,600 -12.1% 2.90 US$1,155,940
2024-04-03 2024-04-01 S Sale
3.7
Cormorant Asset Management, LP
Large shareholder
280 -0.0%
2.97
US$832 		280 -0.0% 2.97 US$832
2024-04-03 2024-04-01 S Sale
3.7
Cormorant Asset Management, LP
Large shareholder
10 -0.0%
2.98
US$30 		10 -0.0% 2.98 US$30
2024-04-03 2024-04-01 S Sale
3.7
Cormorant Asset Management, LP
Large shareholder
10 -0.0%
3.01
US$30 		10 -0.0% 3.01 US$30
2024-04-03 2024-04-01 S Sale
3.7
Cormorant Asset Management, LP
Large shareholder
600 -0.0%
3.03
US$1,818 		600 -0.0% 3.03 US$1,818
2024-04-03 2024-04-01 S Sale
3.7
Cormorant Asset Management, LP
Large shareholder
100 -0.0%
3.05
US$305 		100 -0.0% 3.05 US$305
2024-04-03 2024-04-01 S Sale
3.7
Cormorant Asset Management, LP
Large shareholder
300 -0.0%
3.07
US$920 		300 -0.0% 3.07 US$920
2024-04-03 2024-04-01 S Sale
3.7
Cormorant Asset Management, LP
Large shareholder
100 -0.0%
3.07
US$307 		100 -0.0% 3.07 US$307
2024-03-25 2024-03-22 B Purchase
4.0
Schall Thomas J.
Non-Executive Director
2,900 +inf%
2.55
US$7,385 		2,900 +inf% 2.55 US$7,385
2024-03-25 2024-03-22 B Purchase
2.6
Feinberg Peter
Non-Executive Director
25,000 +28.8%
2.55
US$63,712 		25,000 +28.8% 2.55 US$63,712
2024-03-25 2024-03-22 B Purchase
3.3
Brakewood Harold Eugene

Chief Business Officer

Officer
3,900 +inf%
2.57
US$10,015 		3,900 +inf% 2.57 US$10,015
2024-03-25 2024-03-22 B Purchase
1.4
Morales Mallory

Chief Accounting Officer

Officer
393 +5.0%
2.55
US$1,000 		393 +5.0% 2.55 US$1,000
2024-03-25 2024-03-21 B Purchase
1.4
Morales Mallory

Chief Accounting Officer

Officer
1,107 +16.3%
2.72
US$3,009 		1,107 +16.3% 2.72 US$3,009
2024-03-21 2024-03-20 B Purchase
3.9
Hall Brett Matthew

CHIEF SCIENTIFIC OFFICER

Officer
7,000 +2.1%
2.86
US$20,020 		7,000 +2.1% 2.86 US$20,020
2024-03-21 2024-03-20 B Purchase
2.6
Neufeld Leah R

CHIEF PEOPLE OFFICER

Officer
3,818 +61.5%
2.88
US$10,993 		3,818 +61.5% 2.88 US$10,993
2024-03-19 2024-03-19 B Purchase
2.6
Feinberg Peter
Non-Executive Director
25,000 +40.5%
2.56
US$64,000 		25,000 +40.5% 2.56 US$64,000
2024-03-19 2024-03-19 B Purchase
3.4
Zeskind Benjamin J.

PRESIDENT AND CEO

Executive Director Large shareholder
20,000 +0.9%
2.77
US$55,326 		20,000 +0.9% 2.77 US$55,326
2024-03-19 2024-03-18 B Purchase
2.6
Feinberg Peter
Non-Executive Director
4,976 +8.8%
3.05
US$15,201 		4,976 +8.8% 3.05 US$15,201
2024-03-19 2024-03-18 B Purchase
2.6
Feinberg Peter
Non-Executive Director
45,024 +382.7%
2.31
US$103,857 		45,024 +382.7% 2.31 US$103,857
2024-03-19 2024-03-18 B Purchase
3.0
BERMAN ANN E
Non-Executive Director
57,965 +610.2%
2.13
US$123,436 		57,965 +610.2% 2.13 US$123,436
2024-03-18 2024-03-15 S Sale
3.7
Cormorant Asset Management, LP
Large shareholder
400,000 -10.8%
2.14
US$856,400 		400,000 -10.8% 2.14 US$856,400
2024-03-18 2024-03-14 S Sale
3.7
Cormorant Asset Management, LP
Large shareholder
11,040 -0.3%
5.97
US$65,887 		11,040 -0.3% 5.97 US$65,887
2024-03-18 2024-03-14 S Sale
3.7
Cormorant Asset Management, LP
Large shareholder
54,215 -1.4%
5.37
US$291,351 		54,215 -1.4% 5.37 US$291,351
2024-03-18 2024-03-14 S Sale
3.7
Cormorant Asset Management, LP
Large shareholder
98,570 -2.6%
4.25
US$418,430 		98,570 -2.6% 4.25 US$418,430
2024-03-18 2024-03-14 S Sale
3.7
Cormorant Asset Management, LP
Large shareholder
345,266 -8.2%
3.24
US$1,116,936 		345,266 -8.2% 3.24 US$1,116,936
2022-05-27 2022-05-25 B Purchase
3.9
Hall Brett Matthew

CHIEF SCIENTIFIC OFFICER

Officer
2,551 +0.8%
3.92
US$10,000 		2,551 +0.8% 3.92 US$10,000
2022-05-18 2022-05-17 B Purchase
2.8
Bookman Michael

GENERAL COUNSEL AND SECRETARY

Officer
1,000 +71.3%
4.88
US$4,880 		1,000 +71.3% 4.88 US$4,880
2022-05-17 2022-05-16 B Purchase
2.2
KEATING LAURIE
Non-Executive Director
7,000 +100.0%
5.00
US$35,000 		7,000 +100.0% 5.00 US$35,000
2022-05-12 2022-05-12 B Purchase
3.2
Amin Biren

CFO, TREASURER

Officer
1,000 +14.5%
4.42
US$4,420 		1,000 +14.5% 4.42 US$4,420
2022-03-24 2022-03-23 B Purchase
3.4
Zeskind Benjamin J.

PRESIDENT AND CEO

Executive Director Large shareholder
3,000 +0.1%
8.02
US$24,060 		3,000 +0.1% 8.02 US$24,060
2022-03-23 2022-03-23 B Purchase
3.9
Hall Brett Matthew

CHIEF SCIENTIFIC OFFICER

Officer
1,050 +0.3%
7.91
US$8,306 		1,050 +0.3% 7.91 US$8,306
2022-03-22 2022-03-22 B Purchase
2.1
Barrett Scott

CHIEF MEDICAL OFFICER

Officer
900 +13.5%
7.49
US$6,736 		900 +13.5% 7.49 US$6,736
2022-03-16 2022-03-15 B Purchase
2.6
Feinberg Peter
Non-Executive Director
6,667 +130.8%
6.75
US$45,002 		6,667 +130.8% 6.75 US$45,002
2022-03-15 2022-03-15 B Purchase
3.0
BERMAN ANN E
Non-Executive Director
6,000 +171.4%
6.40
US$38,400 		6,000 +171.4% 6.40 US$38,400
2021-09-14 2021-09-13 B Purchase
3.4
Zeskind Benjamin J.

PRESIDENT AND CEO

Executive Director Large shareholder
2,083 +0.1%
22.87
US$47,632 		2,083 +0.1% 22.87 US$47,632
2021-08-04 2021-08-03 B Purchase
2.6
Feinberg Peter
Non-Executive Director
33,333 +40.6%
15.00
US$499,995 		33,333 +40.6% 15.00 US$499,995
2021-08-04 2021-08-03 B Purchase
2.6
Feinberg Peter
Non-Executive Director
129,167 +37.2%
15.00
US$1,937,505 		129,167 +37.2% 15.00 US$1,937,505
2021-08-04 2021-08-03 B Purchase
2.6
Feinberg Peter
Non-Executive Director
129,167 +50.2%
15.00
US$1,937,505 		129,167 +50.2% 15.00 US$1,937,505
2021-08-04 2021-08-03 B Purchase
3.2
Amin Biren

CFO, Treasurer

Officer
4,175 +153.3%
15.00
US$62,625 		4,175 +153.3% 15.00 US$62,625
Explore more

More insider trading research around Immuneering Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America